Conneqt Health Limited, formerly CardieX Limited, is an Australia-based digital health...Conneqt Health Limited, formerly CardieX Limited, is an Australia-based digital health technology company that develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. The Company's suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular diseases, and other vascular health disorders, all based on its SphygmoCor vascular biomarker technology. Its SphygmoCor vascular biosensing technology measures arterial health by collecting clinically meaningful digital vascular biomarkers using novel sensors. These biomarkers represent key indicators of cardiovascular health including central blood pressures, vascular stiffness, vascular age, and heart stress. It offers CONNEQT, which is a clinical-grade arterial assessment that provides professional-level arterial health insights.More
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
ASX News
